Federal Circuit Rules For Pfizer In Suit Over Norvasc Patent
In a closely watched case, the U.S. Court of Appeals for the Federal Circuit has ruled that Indian generic drug manufacturer Dr Reddy's Laboratories infringed on Pfizer Pharmaceutical company's patent for...To view the full article, register now.
Already a subscriber? Click here to view full article